2025 Press Releases
Rare Uterine Condition Mimics Cancer in Postmenopausal Woman
2025-02-19
“This case highlights an important variant of Adenomyosis that potentially mimics an invasive uterine neoplasm.”
BUFFALO, NY - February 19, 2025 – A new case report was published in Oncoscience's Volume 12 on February 10, 2025, titled “Diffuse cystic adenomyosis simulating invasive uterine neoplasm on imaging: A postmenopausal diagnostic perplexity!”
Researchers Anusha Devalla, Mishu Mangla, Krishna Ramavath, Shailaja Prabhala, Naina Kumar, and Aparna Jarathi from All India Institute of
Severe Osteoporosis as a Manifestation of Systemic Mastocytosis
2025-02-13
“This report highlights the diagnostic challenges of SM, emphasize its underrecognized role in osteoporosis and fragility fractures, and advocates for its consideration in patients with unexplained skeletal abnormalities.”
BUFFALO, NY - February 13, 2025 – A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.”
First author Areti Kalfoutzou, and colleagues from the 251 Air Force
Cervical Cancer: Maternal, Delivery & Neonatal Outcomes Study
2025-02-05
“Our study aims to address the knowledge gap regarding the outcomes of cervical cancer on both maternal and fetal health.”
BUFFALO, NY - February 5, 2025 – A new research paper was published in Oncoscience's Volume 12 on January 20, 2025, titled, “Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database.”
In this large study, researchers Aaron Samuels, Ahmad Badeghiesh, Haitham Baghlaf, and Michael H. Dahan – from McGill University, King
How Pomalidomide Boosts the Immune System to Fight Multiple Myeloma
2025-01-23
“It has been postulated that the clinical benefit of adding POM results from enhanced immunocompetency.”
BUFFALO, NY - January 23, 2025 – A new editorial was published in Oncoscience's Volume 12 on January 14, 2025, titled, “Pomalidomide improved immune profiles in myeloma.”
The editorial by researchers Hannah Seah, Vaishnavi Reddy Bade, Lakshmi Bhavani Potluri, Srikanth Talluri, and Rao H. Prabhala from Dana-Farber Cancer Institute, VA Boston Healthcare System, and Harvard Medical